酒精激活ATF4/LPLA2介导的BMP代谢增强HBV诱导的肝细胞癌发生
该研究探讨酒精促进HBV相关肝细胞癌(HCC)的分子机制。在HBx转基因小鼠和裸鼠移植瘤模型中,慢性乙醇摄入促进肿瘤发生,肿瘤中BMP种类显著增加且归因于LPLA2上调。机制上ATF4直接结合LPLA2启动子促进其转录,LPLA2通过激活MAPK/ERK通路促进肿瘤细胞增殖,而LPLA2沉默可消除乙醇促癌作用。
要点
- 慢性乙醇摄入促进HBx转基因小鼠自发肿瘤发生和裸鼠移植瘤进展
- ATF4直接结合LPLA2启动子促进转录,LPLA2上调增加BMP种类
- LPLA2通过MAPK/ERK通路促增殖,沉默LPLA2消除乙醇促癌作用
核心结论
- 酒精通过激活ATF4/LPLA2介导的BMP代谢增强HBV诱导的HCC发生。
- LPLA2可能作为HCC患者的治疗靶点和预后标志物。
研究设计与样本
- 使用HBx转基因小鼠和裸鼠移植瘤模型评估乙醇的促肿瘤作用。
- 分析人肝组织和血清样本、小鼠模型及HepG2.215和Hep3B细胞系评估LPLA2表达和致癌效应。
- 采用液相色谱-质谱法评估脂质谱。
主要发现
- 慢性乙醇摄入促进HBx转基因小鼠自发肿瘤发生并加速裸鼠皮下肿瘤进展。
- 乙醇喂养HBx转基因小鼠肿瘤中BMP种类显著增加,归因于LPLA2上调。
- ATF4通过直接启动子结合促进LPLA2转录活性。
- LPLA2过表达通过激活MAPK/ERK通路在体外和体内促进肿瘤细胞增殖,LPLA2沉默消除乙醇促癌作用。
- BMP合酶CLN5过表达和BMP补充激活MAPK/ERK通路促进HCC增殖,CLN5敲低抵消LPLA2的促增殖作用。
关键数值与推荐
- LPLA2上调与HCC患者不良预后相关。
临床怎么用
- 靶向LPLA2或BMP代谢可显著抑制HBV-HCC进展。
- 该临床前研究为探索HCC治疗新策略提供理论依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIM: Chronic alcohol consumption synergistically enhances hepatocellular carcinoma (HCC) risk in HBV-infected individuals. However, the pivotal molecular mechanisms remain elusive. METHODS: HBx-transgenic (HBx-Tg) mice and nude mouse xenograft models were used to evaluate the tumor-promoting effects of ethanol. Human liver tissues and serum samples, mouse models, HepG2.215 and Hep3B cell lines were analyzed to assess the expression and oncogenic effects of lysosomal phospholipase A2 (LPLA2). Lipid profiles were assessed using liquid chromatography-mass spectrometry. RESULTS: Chronic ethanol intake promoted spontaneous tumorigenesis in HBx-Tg mice and accelerated subcutaneous tumor progression in nude mice. Liquid chromatography-mass spectrometry analysis revealed a significant increase in bis(monoacylglycero)phosphate (BMP) species in the tumors of ethanol-fed HBx-Tg mice, attributable to the upregulation of LPLA2. Mechanistic studies showed that activating transcription factor 4 (ATF4) promoted the transcriptional activity of LPLA2 through direct promoter binding. LPLA2 overexpression promoted tumor cell proliferation in vitro and in vivo by activating the MAPK/ERK signaling pathway, whereas LPLA2 silencing effectively abrogated ethanol-promoted hepatocarcinogenesis. Overexpression of BMP synthase CLN5 and BMP supplementation activated the MAPK/ERK signaling pathway, thereby promoting HCC proliferation. Knockdown of CLN5 counteracted the tumor-promoting proliferation of LPLA2. Clinically, the upregulation of LPLA2 is associated with poor prognosis in patients with HCC. CONCLUSION: Our data demonstrate that alcohol activates ATF4/LPLA2-mediated BMP metabolism, enhancing HBV-induced HCC. LPLA2 may serve as a therapeutic target and prognostic marker in patients with HCC. IMPACT AND IMPLICATIONS: Chronic alcohol consumption promotes HBV-induced hepatocellular carcinogenesis (HBV-HCC). ATF4/LPLA2-mediated BMP metabolism promotes alcohol-enhanced HBV-HCC via the MAPK/ERK signaling pathway. Targeting LPLA2 or BMP metabolism markedly inhibited HBV-HCC progression. This preclinical study provides a theoretical basis to investigate novel strategies for HCC therapy.
引用
- Zhou H, Ba J, Xiao C, et al. Alcohol activates ATF4/LPLA2-mediated BMP metabolism to enhance HBV-induced hepatocellular carcinogenesis. J Hepatol. 2025. PMID: 40885211. doi:10.1016/j.jhep.2025.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。